Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$3.695 -2.76%
Market Cap
$106.5M
Price Target
Refer to Report
Volume
719.1K
52wk Range
$1.34 - $4.05
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.